JOURNAL OF COSMETIC SCIENCE 216 Earlier market research had indicated that the addition of cooling attributes to the exist- ing BACTROBAN® disinfectant spray was desirable by consumers. In the pivotal study, although there was a signifi cant increase in consumer perceived cooling from the proto- type formulation, this did not correspond to a signifi cant increase in overall product lik- ing for the prototype compared with the existing marketed product in this study. CONCLUSIONS Experimental wound models are an effective means of evaluating sensory characteristics of disinfectant sprays. The prototype formulation containing a cooling agent delivered signifi cantly more cool- ing sensation than both BACTROBAN® disinfectant spray and the negative control product on experimental wounds at 3 and 5 min after product application, and overall for a 15-min period after application. No statistically signifi cant differences in product liking were observed between the pro- totype disinfectant spray compared with BACTROBAN® disinfectant spray formula- tions or negative control product. The prototype disinfectant spray, BACTROBAN® disinfectant Spray, and control prod- ucts were well-tolerated in these studies. ACKNOWLEDGMENTS This study was sponsored by GlaxoSmithKline (China) Investment Co., Ltd. Hereon we give our sincere thanks to all the subjects, investigators, and healthcare providers who had been involved in this clinical trial. The authors would also like to thank Alex Selmani (statistician) for his input to the original pilot study and report and MMR for their sen- sory expertise. REFERENCES (1) E . Proksch, J. M. Brandner, and J. M. Jensen, The skin: An indispensable barrier, Exp. Dermatol., 17(12), 1063–1072 (2008). (2) K . C. Madison, Barrier function of the skin: “la raison d’être” of the epidermis, J. Invest. Dermatol., 121(2), 231–241 (2003). (3) J. G. Thomas, and S. L. Percival, Indigenous microbiota and association with the host, in Microbiology and Aging: Clinical Manifestations, S. L. Percival, Ed. (Humana Press, New York, 2008), pp. 15–38. (4) S. L. Percival, C. Emanuel, K. F. Cutting, and D. W. Williams, Microbiology of skin and role of bio- fi lms, Int. Wound J., 9, 14–32 (2011). (5) J. S. Boateng, K. H. Matthews, H. N. E. Stevens, and G. M. Eccleston, Wound healing dressings and drug delivery systems: A review, J. Pharm. Sci., 97(8), 2892–2923 (2008). (6) A. Gravett, S. Sterner, J. E. Clinton, and E. Ruiz, A trial of povidone-iodine in the prevention of infec- tion in sutured lacerations, Ann. Emerg. Med., 16(2), 167–171 (1987). (7) T. Kunisada, K. Yamada, S. Oda, and O. Hara, Investigation on the effi cacy of povidoneiodine against antiseptic-resistant species, Dermatology, 195(Suppl 2), 14–18 (1997). (8) B. Marple, P. Roland, and M. Benninger, Safety review of benzalkonium chloride used as a preservative in intranasal solutions: An overview of confl icting data and opinions, Otolaryngol. Head Neck Surg., 130(1), 131–141 (2004). (9) Un ited States Food and Drug Administration, Topical anti-microbial drug products for over-the-counter human use tentative fi nal monograph for fi rst aid antiseptic drug products Docket No. 75N-183F.

EVALUATE SKIN DISINFECTANT SPRAY 217 (10) U nited States Food and Drug Administration, Topical anti-microbial drug products for over-the-counter human use tentative fi nal monograph for health-care antiseptic drug products Docket No. 75N-183H. (11) R . Eccles, Menthol and related cooling compounds, J. Pharm. Pharmacol., 46(8), 618–630 (1994). (12) T . Patel, Y. Ishiuji, and G. Yosipovitch, Menthol: A refreshing look at this ancient compound, J. Am. Acad. Dermatol., 57(5), 873–878 (2007). (13) S . S. Bharate and S. B. Bharate, Modulation of thermoreceptor TRPM8 by cooling compounds, ACS Chem. Neurosci. 3, 248–267 (2012). (14) N . R. Gavva, C. Davis, S. G. Lehto, S. Rao, W. Wang, and D. X. Zhu, Transient receptor potential melastatin 8 (TRPM8) channels are involved in body temperature regulation, Mol. Pain., 8, 36 (2012). (15) D . N. Ruskin, R. Anand, and G. J. LaHoste, Menthol and nicotine oppositely modulate body tempera- ture in the rat, Eur. J. Pharmacol., 559(2–3), 161–164 (2007). (16) A . Pagnoni, G. Spinelli, R. S. Berger, J. Bowman, S. Garreffa, and A. M. Snoddy, Lack of burning and stinging from a novel fi rst-aid formulation applied to experimental wounds, J. Cosmet. Sci., 55(2), 157– 162 (2004). (17) S . J. Bashir, A. L. Chew, A. Anigbogu, F. Dreher, and H. I. Maibach, Physical and physiological effects of stratum corneum tape stripping, Skin Res. Technol., 7(1), 40–48 (2001). (18) N . Q. Phan, C. Blome, F. Fritz, J. Gerss, A. Reich, T. Ebata, M. Augustin, J. Szepietowski, and S. Stander, Assessment of pruritus intensity: Prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus, Acta Derm Venereol., 92, 502–507 (2012). (19) M . J. Hjermstad, P. M. Fayers, D. F. Haugen, A. Caraceni, G. W. Hanks, J. H. Loge, R. Fainsinger, N. Aass, and S. Kaasa. Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: A systematic literature review, J. Pain Symptom Manag., 41(6), 1073–1093 (2011).